Literature DB >> 25208190

Cortical thickness and neurocognition in adolescent marijuana and alcohol users following 28 days of monitored abstinence.

Joanna Jacobus1, Lindsay M Squeglia2, Scott F Sorg3, Tam T Nguyen-Louie4, Susan F Tapert1.   

Abstract

OBJECTIVE: Adolescent marijuana use continues to increase in prevalence as harm perception declines. Better understanding of marijuana's impact on neurodevelopment is crucial. This prospective study aimed to investigate cortical thickness and neurocognitive performance before and after 28 days of monitored abstinence in adolescent marijuana and alcohol users.
METHOD: Subjects (N = 54; >70% male) were adolescent marijuana users (ages 15-18 years) with regular alcohol use (MJ + ALC; n = 24) and non-using controls (CON; n = 30) who were compared before and after 4 weeks of sequential urine toxicology to confirm abstinence. Participants underwent magnetic resonance imaging, neuropsychological assessment, and substance use assessment at both time points. Repeated-measures analysis of covariance was used to look at the main effects of group, time, and Group × Time interactions on cortical thickness and neurocognitive functioning. Bivariate correlations estimated associations between cortical thickness, substance use severity, and cognitive performance.
RESULTS: Marijuana users showed thicker cortices than controls in the left entorhinal cortex (ps < .03) before and after monitored abstinence, after adjusting for lifetime alcohol use. More lifetime marijuana use was linked to thinner cortices in temporal and frontal regions, whereas more lifetime alcohol use and heavy episodic drinking episodes was linked to thicker cortices in all four lobes (ps < .05). Age of onset of regular marijuana use was positively related to cortical thickness (ps < .03).
CONCLUSIONS: Adolescent alcohol and marijuana use may be linked to altered longer-term neurodevelopmental trajectories and compromised neural health. Cortical thickness alterations and dose-dependent associations with thickness estimates were observed both before and after monitored abstinence and suggest neural differences continue to persist 28 days after cessation of marijuana use. Neural recovery may be identified with longer follow-up periods; however, observed changes related to use severity could have implications for future psychosocial outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 25208190      PMCID: PMC4161693          DOI: 10.15288/jsad.2014.75.729

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  83 in total

1.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

2.  The DISC Predictive Scales (DPS): efficiently screening for diagnoses.

Authors:  C P Lucas; H Zhang; P W Fisher; D Shaffer; D A Regier; W E Narrow; K Bourdon; M K Dulcan; G Canino; M Rubio-Stipec; B B Lahey; P Friman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-04       Impact factor: 8.829

3.  Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults.

Authors:  Krista M Lisdahl; Jenessa S Price
Journal:  J Int Neuropsychol Soc       Date:  2012-05-22       Impact factor: 2.892

4.  Simultaneous alcohol and marijuana use among U.S. high school seniors from 1976 to 2011: trends, reasons, and situations.

Authors:  Yvonne M Terry-McElrath; Patrick M O'Malley; Lloyd D Johnston
Journal:  Drug Alcohol Depend       Date:  2013-06-24       Impact factor: 4.492

5.  Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers.

Authors:  Staci A Gruber; Marisa M Silveri; Mary Kathryn Dahlgren; Deborah Yurgelun-Todd
Journal:  Exp Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.157

6.  fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders.

Authors:  Alecia D Schweinsburg; Brian C Schweinsburg; Erick H Cheung; Gregory G Brown; Sandra A Brown; Susan F Tapert
Journal:  Drug Alcohol Depend       Date:  2005-02-26       Impact factor: 4.492

7.  Preliminary evidence for a sex-specific relationship between amount of cannabis use and neurocognitive performance in young adult cannabis users.

Authors:  Natania A Crane; Randi Melissa Schuster; Raul Gonzalez
Journal:  J Int Neuropsychol Soc       Date:  2013-08-20       Impact factor: 2.892

8.  Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects.

Authors:  Krista Lisdahl Medina; Tim McQueeny; Bonnie J Nagel; Karen L Hanson; Tony T Yang; Susan F Tapert
Journal:  Addict Biol       Date:  2009-07-24       Impact factor: 4.280

9.  Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey.

Authors:  Lorraine T Midanik; Tammy W Tam; Constance Weisner
Journal:  Drug Alcohol Depend       Date:  2007-04-18       Impact factor: 4.492

10.  Impulsivity, attention, memory, and decision-making among adolescent marijuana users.

Authors:  Donald M Dougherty; Charles W Mathias; Michael A Dawes; R Michael Furr; Nora E Charles; Anthony Liguori; Erin E Shannon; Ashley Acheson
Journal:  Psychopharmacology (Berl)       Date:  2012-11-09       Impact factor: 4.530

View more
  40 in total

1.  Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness.

Authors:  Milena Radoman; Susanne S Hoeppner; Randi M Schuster; A Eden Evins; Jodi M Gilman
Journal:  Cogn Affect Behav Neurosci       Date:  2019-08       Impact factor: 3.282

2.  Neuropsychological performance in adolescent marijuana users with co-occurring alcohol use: A three-year longitudinal study.

Authors:  Joanna Jacobus; Lindsay M Squeglia; M Alejandra Infante; Norma Castro; Ty Brumback; Alejandro D Meruelo; Susan F Tapert
Journal:  Neuropsychology       Date:  2015-05-04       Impact factor: 3.295

Review 3.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.

Authors:  Benedikt Fischer; Cayley Russell; Pamela Sabioni; Wim van den Brink; Bernard Le Foll; Wayne Hall; Jürgen Rehm; Robin Room
Journal:  Am J Public Health       Date:  2017-06-23       Impact factor: 9.308

Review 4.  Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults.

Authors:  Florian Ganzer; Sonja Bröning; Stefanie Kraft; Peter-Michael Sack; Rainer Thomasius
Journal:  Neuropsychol Rev       Date:  2016-04-28       Impact factor: 7.444

Review 5.  Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders.

Authors:  Nora L Nock; Sonia Minnes; Jay L Alberts
Journal:  Birth Defects Res       Date:  2017-12-01       Impact factor: 2.344

6.  Substance use initiation and the prediction of subsequent academic achievement.

Authors:  Alejandro D Meruelo; Norma Castro; Tam Nguyen-Louie; Susan F Tapert
Journal:  Brain Imaging Behav       Date:  2020-12       Impact factor: 3.978

Review 7.  Alcohol and Drug Use and the Developing Brain.

Authors:  Lindsay M Squeglia; Kevin M Gray
Journal:  Curr Psychiatry Rep       Date:  2016-05       Impact factor: 5.285

8.  Short-term E-cigarette toxicity effects on brain cognitive memory functions and inflammatory responses in mice.

Authors:  E S Prasedya; Y Ambana; N W R Martyasari; Ye'muh Aprizal
Journal:  Toxicol Res       Date:  2020-02-04

9.  Aerobic Fitness Level Moderates the Association Between Cannabis Use and Executive Functioning and Psychomotor Speed Following Abstinence in Adolescents and Young Adults.

Authors:  Natasha E Wade; Alexander L Wallace; Ann M Swartz; Krista M Lisdahl
Journal:  J Int Neuropsychol Soc       Date:  2018-11-26       Impact factor: 2.892

Review 10.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.